Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats-Reference-Cited by-同舟云学术

Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats

Published:2024-09-06 Issue: Volume: Page:
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol.

Author:

Brakatselos Charalampos^ORCID,Polissidis Alexia,Ntoulas George,Asprogerakas Michail-Zois,Tsarna Olga,Vamvaka-Iakovou Anastasia,Nakas Gerasimos,Delis Anastasios,Tzimas Petros,Skaltsounis Leandros,Silva Joana,Delis Foteini,Oliveira Joao Filipe^ORCID,Sotiropoulos Ioannis,Antoniou Katerina^ORCID

Funder

General Secretariat for Research and Technology

"la Caixa" Foundation

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41386-024-01977-1.pdf

Reference118 articles.

1. McCutcheon RA, Reis Marques T, Howes OD. Schizophrenia—An Overview. JAMA Psychiatry. 2020;77:201–10.

2. Sotiropoulos MG, Poulogiannopoulou E, Delis F, Dalla C, Antoniou K, Kokras N. Innovative screening models for the discovery of new schizophrenia drug therapies: an integrated approach. Expert Opin Drug Discov. 2021;16:791–806.

3. Reid MA, Salibi N, White DM, Gawne TJ, Denney TS, Lahti AC. 7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia. Schizophr Bull. 2019;45:180–9.

4. Wang AM, Pradhan S, Coughlin JM, Trivedi A, DuBois SL, Crawford JL, et al. Assessing Brain Metabolism With 7-T Proton Magnetic Resonance Spectroscopy in Patients With First-Episode Psychosis. JAMA Psychiatry. 2019;76:314–23.

5. Taylor R, Neufeld RWJ, Schaefer B, Densmore M, Rajakumar N, Osuch EA, et al. Functional magnetic resonance spectroscopy of glutamate in schizophrenia and major depressive disorder: anterior cingulate activity during a color-word Stroop task. NPJ Schizophr. 2015;1:15028.